{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:07:51Z","timestamp":1778476071437,"version":"3.51.4"},"reference-count":40,"publisher":"Korean Association of Internal Medicine","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["kjim.org"],"crossmark-restriction":true},"short-container-title":["Korean J Intern Med"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:p>Eperisone hydrochloride is a centrally acting muscle relaxant commonly prescribed for musculoskeletal pain, particularly in Korea and Japan. It induces relaxation of skeletal and vascular smooth muscle through central nervous system modulation and peripheral mechanisms, although its precise biochemical pathway remains unclear. While generally well tolerated, eperisone has been reported to cause immediate hypersensitivity reactions, including anaphylaxis. Because eperisone is frequently co-prescribed with non-steroidal anti-inflammatory drugs (NSAIDs), these reactions are often misdiagnosed as NSAID hypersensitivity, leading to unnecessary drug discontinuation and suboptimal pain management. A review of published case reports and pharmacovigilance data indicates that most eperisone-associated reactions are immediate-type, with anaphylaxis being clinically significant yet underrecognized. Skin prick tests and intradermal tests show variable diagnostic reliability, whereas drug provocation tests (DPTs) demonstrate the highest diagnostic accuracy and remain the gold standard. Basophil activation tests and serum tryptase measurement during DPT may serve as complementary diagnostic tools. Accurate identification of eperisone hypersensitivity is essential for preventing recurrent anaphylaxis and avoiding unnecessary NSAID discontinuation. This review summarizes the epidemiology, clinical features, and diagnostic strategies of eperisone hypersensitivity and emphasizes the importance of enhancing clinical awareness and referring affected patients to allergy specialists for proper evaluation.<\/jats:p>","DOI":"10.3904\/kjim.2025.341","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:53:44Z","timestamp":1777535624000},"page":"411-417","update-policy":"https:\/\/doi.org\/10.3904\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Eperisone-induced immediate hypersensitivity reactions"],"prefix":"10.3904","volume":"41","author":[{"given":"Gyu-Young","family":"Hur","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0249-8749","authenticated-orcid":true,"given":"Jung-Won","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2270","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-17900-1_72"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c24-00032"},{"key":"ref3","first-page":"459","volume-title":"Effect of a centrally-acting muscle relaxant, eperisone hydrochloride, on muscle sympathetic nerve activity in humans","author":"Iwase","year":"1992"},{"key":"ref4","first-page":"237","volume-title":"","author":"Mano","year":"1981"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000077449"},{"key":"ref6","first-page":"221","volume-title":"Effects of eperisone hydrochloride and non-steroid anti-inflammatory drugs (NSAIDs) for acute non-specific back pain with muscle spasm: a prospective, open-label study","author":"Pinzon","year":"2020"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.11.020"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000034818"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2021.13.2.171"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2003.10280"},{"key":"ref11","first-page":"411","volume-title":"An immediate hypersensitivity reaction caused by tolperisone hydrochloride","author":"Gl\u00fcck","year":"2011"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2024.116532"},{"key":"ref13","first-page":"229","volume-title":"Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study","author":"Cabitza","year":"2008"},{"key":"ref14","first-page":"278","volume-title":"Evaluation of eperisone hydrochloride in the treatment of acute musculoskeletal spasm associated with low back pain: a randomized, double-blind, placebo-controlled trial","author":"Chandanwale","year":"2011"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1240526"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3109\/15563650903524126"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2019.1592186"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2012.53.4.863"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4168\/aard.2013.1.2.172"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4168\/aard.2017.5.4.228"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2016.07.004"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2019.11.2.231"},{"key":"ref23","first-page":"279","volume-title":"Clinical characteristics of eperisone-induced immediate-type hypersensitivity","author":"Shin","year":"2020"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2022.0172"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/all.12142"},{"key":"ref26","first-page":"1333","volume-title":"Drug allergy: a 2022 practice parameter update","author":"Khan","year":"2022"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2014.08.001"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/all.15996"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2003.00279.x"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/all.14122"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.10.066"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.12.005"},{"key":"ref33","first-page":"138","volume-title":"The nocebo effect during oral challenge in subjects with adverse drug reactions","author":"Lombardi","year":"2008"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00494"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/wox.0b013e318211496c"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/all.13752"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/all.15032"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/all.15957"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/all.14747"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2016.8.6.541"}],"container-title":["The Korean Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/kjim.org\/upload\/kjim-2025-341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/kjim.org\/journal\/view.php?doi=10.3904\/kjim.2025.341","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/kjim.org\/upload\/kjim-2025-341.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:11:02Z","timestamp":1778472662000},"score":1,"resource":{"primary":{"URL":"http:\/\/kjim.org\/journal\/view.php?doi=10.3904\/kjim.2025.341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"URL":"https:\/\/doi.org\/10.3904\/kjim.2025.341","relation":{},"ISSN":["1226-3303","2005-6648"],"issn-type":[{"value":"1226-3303","type":"print"},{"value":"2005-6648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"2025-10-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-01","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-01","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}